Cimatron_Teaser

Is 3D Systems Losing Focus by Acquiring Cimatron?

We've written in previous articles about the large number of acquisitions that 3D Systems seems to engage in over time and the broad types of companies they like to acquire. In November of 2014, 3D Systems (NYSE:DDD) announced a definitive agreement to acquire Cimatron, a deal that was finalized just yesterday for around $97 million. With the deal now closed, just what has 3D Systems acquired?     Founded in 1982 and with more than 40,000 installations worldwide, Israeli based Cimatron (NASDAQ:CIMT) is a leading provider of integrated, CAD/CAM software solutions for mold, tool and die makers. Their flagship product is CimatronE, an integrated CAD/CAM software solution. This 200 employee company has showed steady revenue growth and has been profitable for the past 5 years. Revenues for 2013 were $44.25 million with net income of $4.85 million and a dividend declared. While Cimatron appears to be [...]

Principal_Solar_Teaser

Can Principal Solar Become A Solar Utility?

In previous articles we've discussed how investors should avoid over-the-counter companies at all costs. With rare exceptions, 99% of the time long term investors who buy into the promises of OTC companies will end up losing their investments in the long run. Whether with malicious intent or not, the management of these companies will often publish their scientific accomplishments and promises of future revenues through frequent company press releases, and while speculators may make money on the long and short sides, long term investors almost always lose. Nonetheless, each OTC company should be evaluated on its own merits. One OTC company, Principal Solar, is looking to become a utility-scale solar operation, and announced today that it plans to build the largest solar facility east of the Rockies.         Principal Solar (OTCMKTS:PSWW) was incorporated in 2010 and began [...]

NANTHEALTH_Teaser

Will a NantHealth IPO Happen in 2015?

        In a June 2014 article we highlighted a company called NantHealth, led by Patrick Soon-Shiong who is the wealthiest American in the healthcare industry having amassed a fortune of $7.2 billion for building and selling  Abraxis Biosciences and American Pharma Partners. NantHealth is building what is referred to as the “clinical operating system” (cOS) which promises to revolutionize cancer treatment through aggregating and analyzing cancer patient data. The Company has already spent $1.5 billion in the past decade and most recently completed a $320 million dollar Series B investment round in October of 2014 bringing a total of $818 million raised in the last six months alone from sovereign wealth funds and private equity groups. This is a massive amount of funding raised in a very short period of time. While NantHealth sounds like an incredibly promising company, a recent [...]

D-Wave_Teaser

Investing in Quantum Computing with TINY and D-Wave

We've talked before about disruptive technology venture capital fund Harris and Harris Group (NASDAQ:TINY) and their dismal share price performance over time. We've also highlighted that any single successful exit for one of TINY's larger investments could be quite beneficial for TINY's shareholders. Let's take a look at an investment by Harris and Harris Group in D-Wave, a Canadian quantum computing company that has the potential to be truly disruptive. Why Quantum Computing? Quantum computing has always been thought of as the holy grail for technologists. Just why is this the case? Well the simple explanation requires a bit of background. In computing, there is a rule we call Moore's law which states that "computer chip performance doubles every 2 years". Silicon chips, which are the foundation of computing today, will eventually reach their technological limit. Quantum computing promises a solution that would [...]

Nanotech_Security_Teaser

How “Nano” is Nanotech Security Corporation?

        Nanotech Security Corporation trades on the TSX Venture Exchange (CVE:NTS) and in February 2014 listed on the over-the-counter (OTC) market (OTCMKTS:NTSFF) with a market cap of $45 million. Initially started as a company that provided home surveillance systems for criminals on probation, the company dabbled for a bit in wireless solutions in 2007. Fast forward to today and they now have two business areas in focus. The first is a fully owned subsidiary called Tactical Technologies Inc. which manufactures and sells surveillance equipment to the law enforcement and defense industries in the U.S. and Canada. The second is their KolourOptik™ and Plasmogram™ products which are nanotechnology based product platforms originally inspired by the unique optical properties of the iridescent wings of the Blue Morpho butterfly. These platforms produce an Optical Thin Film (“OTF”) [...]

Lastest Articles

NANTHEALTH_Teaser

Will a NantHealth IPO Happen in 2015?

        In a June 2014 article we highlighted a company called NantHealth, led by Patrick Soon-Shiong who is the wealthiest American in the healthcare industry having amassed a fortune of $7.2 billion for building and selling  Abraxis [...]

Cimatron_Teaser

Is 3D Systems Losing Focus by Acquiring Cimatron?

We've written in previous articles about the large number of acquisitions that 3D Systems seems to engage in over time and the broad types of companies they like to acquire. In November of 2014, 3D Systems (NYSE:DDD) announced a definitive agreement to acquire Cimatron, a [...]

Principal_Solar_Teaser

Can Principal Solar Become A Solar Utility?

In previous articles we've discussed how investors should avoid over-the-counter companies at all costs. With rare exceptions, 99% of the time long term investors who buy into the promises of OTC companies will end up losing their investments in the long run. Whether with [...]

IONA_TEST_TEASER

Premaitha Health’s In Vitro Diagnostic NIPT

Non invasive prenatal testing (NIPT) is a blood test used to  screen pregnant women for chromosome problems, as early as 9 weeks in pregnancy. For investors, this market has tantalizing future growth projections. In a report published last year by Transparency Market [...]